» Articles » PMID: 20407588

Mouse Models for Type 1 Diabetes

Overview
Publisher Elsevier
Date 2010 Apr 22
PMID 20407588
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Our understanding of the genetics, aetiology and pathogenesis of Type 1 Diabetes (T1D) was propelled by the discovery of animal models of T1D in the late 1970s and early 1980s, particularly the non-obese diabetic (NOD) mouse. Since then, transgenic and gene-targeting technologies allowed the generation of many models with reduced genetic and pathogenic complexity. These models allowed researchers to zoom in on specific aspects of this complex disease. In this review, we provide an overview of currently available mouse models for T1D.

Citing Articles

Hyperglycemia in a NOD Mice Model of Type-I Diabetes Aggravates Collagenase-Induced Intracerebral Hemorrhagic Injury.

Alhadidi Q, Nash K, Bahader G, Zender E, McInerney M, Shah Z Biomedicines. 2024; 12(8).

PMID: 39200331 PMC: 11352023. DOI: 10.3390/biomedicines12081867.


Untangling the genetics of beta cell dysfunction and death in type 1 diabetes.

Robertson C, Elgamal R, Henry-Kanarek B, Arvan P, Chen S, Dhawan S Mol Metab. 2024; 86:101973.

PMID: 38914291 PMC: 11283044. DOI: 10.1016/j.molmet.2024.101973.


MiR-144-5p and miR-21-5p do not drive bone disease in a mouse model of type 1 diabetes mellitus.

Daamouch S, Bluher M, Carro Vazquez D, Hackl M, Hofbauer L, Rauner M JBMR Plus. 2024; 8(5):ziae036.

PMID: 38606150 PMC: 11008730. DOI: 10.1093/jbmrpl/ziae036.


Vaccines for immune tolerance against autoimmune disease.

Kim A, Xie F, Abed O, Moon J Adv Drug Deliv Rev. 2023; 203:115140.

PMID: 37980949 PMC: 10757742. DOI: 10.1016/j.addr.2023.115140.


The beta cell-immune cell interface in type 1 diabetes (T1D).

James E, Joglekar A, Linnemann A, Russ H, Kent S Mol Metab. 2023; 78:101809.

PMID: 37734713 PMC: 10622886. DOI: 10.1016/j.molmet.2023.101809.


References
1.
Kyburz D, Aichele P, Speiser D, Hengartner H, Zinkernagel R, Pircher H . T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol. 1993; 23(8):1956-62. DOI: 10.1002/eji.1830230834. View

2.
Saisho Y, Harris P, Butler A, Galasso R, Gurlo T, Rizza R . Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas. J Mol Histol. 2008; 39(5):543-51. PMC: 2566800. DOI: 10.1007/s10735-008-9195-9. View

3.
Garza K, Chan S, Suri R, Nguyen L, Odermatt B, Schoenberger S . Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med. 2000; 191(11):2021-7. PMC: 2213533. DOI: 10.1084/jem.191.11.2021. View

4.
Martinic M, von Herrath M . Real-time imaging of the pancreas during development of diabetes. Immunol Rev. 2008; 221:200-13. DOI: 10.1111/j.1600-065X.2008.00581.x. View

5.
Shoda L, Young D, Ramanujan S, Whiting C, Atkinson M, Bluestone J . A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity. 2005; 23(2):115-26. DOI: 10.1016/j.immuni.2005.08.002. View